Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Srinivas Rao
Recent news which mentions Srinivas Rao
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
Tickers
ATAI
DMT
MDMA
NEWS
Tags
MDMA
Psychedelics Research
Srinivas Rao
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Non/Hallucinogenic Psychedelics
Psychedelic Assisted Therapies
R/MDMA
From
Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
Health Care
Srinivas Rao
treatment/resistant depression
From
Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
August 15, 2022
Tickers
ATAI
HTGC
Tags
Mid Cap
Penny Stocks
Management
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
HSTRF
PSY
PHRRF
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.